Patent details
EP3846810 Title: CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION
Basic Information
- Publication number:
- EP3846810
- PCT Application Number:
- US2019049340
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP197735830
- PCT Publication Number:
- WO2020051137
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION
- French Title of Invention:
- DOSAGE NOCTURNE CHRONIQUE DE LASMIDITAN POUR LA PRÉVENTION DE LA MIGRAINE
- German Title of Invention:
- CHRONISCHE NÄCHTLICHE DOSIERUNG VON LASMIDITAN ZUR MIGRÄNEPRÄVENTION
- SPC Number:
Dates
- Filing date:
- 03/09/2019
- Grant date:
- 18/10/2023
- EP Publication Date:
- 14/07/2021
- PCT Publication Date:
- 12/03/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/10/2023
- EP B1 Publication Date:
- 18/10/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 03/09/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/10/2023
- Name:
- Eli Lilly and Company
- Address:
- Lilly Corporate Center, Indianapolis, IN 46285, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 23/10/2023
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- DAVAR, Gudarz
- Address:
- United States (US)
2
- Name:
- CONLEY, Robert Russell
- Address:
- United States (US)
3
- Name:
- JOHNSON, Kirk Willis
- Address:
- United States (US)
Priority
- Priority Number:
- 201862726585 P
- Priority Date:
- 04/09/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/444; A61P 25/06;
Publication
European Patent Bulletin
1
- Issue number:
- 202342
- Publication date:
- 18/10/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202614
- Publication date:
- 01/04/2026
- Description:
- Opposition rejected; Patent maintained as granted
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 8
- Annual Fee Amount:
- 99 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 20/08/2025
- Last Annual Fee Paid Number:
- 7
- Last Annual Fee Paid Amount:
- 82 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 23/10/2023 | Power Of Attorney | 1 |
| 23/10/2023 | Outgoing Correspondence | 1 |